Your email has been successfully added to our mailing list.

×
-0.00475774347023974 -0.00961258374599478 0.0144674240217496 0.00980677735702495 0.0223322652684726 0.0388872706087969 0.0222351684629575 0.0243712981842899
Stock impact report

OncoSec's ImmunoPulse IL-12 shows encouraging effect in TNBC patients; shares up 13% [Seeking Alpha]

OncoSec Medical Incorporated (ONCS) 
Last oncosec medical incorporated earnings: 12/13 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: oncosec.com/tag/investor-relations
Company Research Source: Seeking Alpha
OncoSec's ImmunoPulse IL-12 shows encouraging effect in TNBC patients; shares up 13%Nano cap OncoSec Medical (ONCS+12.7%) is up on modestly higher volume on the heels of itsannouncement of preliminary positive results from a clinical trial assessing the effect of ImmunoPulse IL-12 in patients with triple-negative breast cancer (TNBC).The study is designed to determine whether a single cycle of ImmunoPulse IL-12 increases the immune response to tumor cells. So far, five TNBC patients have received treatment. Two of the five were subsequently treated with Bristol-Myers Squibb's PD-1 inhibitor Opdivo (nivolumab). Both, after failing to respond to earlier cycles of chemo, experienced robust responses in lesions treated with ImmunoPulse IL-12 as well as untreated lesions.The company says it will commit to a more definitive evaluation of the combination therapy in TNBC patients.ImmunoPulse IL-12 delivers a pulsed electric field to cells via a hand-held applicator which temporarily increases Show less Read more
Impact Snapshot
Event Time:
ONCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ONCS alerts
Opt-in for
ONCS alerts

from News Quantified
Opt-in for
ONCS alerts

from News Quantified